Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0IA0N
|
|||
| Drug Name |
NRL-1
|
|||
| Indication | Acute repetitive seizure [ICD-11: 8A67; ICD-10: G41.2] | Phase 3 | [1] | |
| Epilepsy [ICD-11: 8A60-8A68] | Phase 3 | [2] | ||
| Company |
Neurelis Pharmaceuticals San Diego, CA
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.